✦ LIBER ✦

Effects of cerivastatin in dyslipemia and other cardiovascular risk factors after renal transplantation

✍ Scribed by I Garcia; P Errasti; F.J Lavilla; B Ballester; J Manrique; E Rossich; A Purroy

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular risk factors and diseases

✍ S. Aker; K. Ivens; B. Grabensee; P. Heering 📂 Article 📅 1998 🏛 Springer Netherlands 🌐 English ⚖ 748 KB

Cardiovascular Risk Estimates and Risk F

✍ B.K. Krämer; C. Böger; B. Krüger; J. Marienhagen; M. Pietrzyk; A. Obed; L. Pacze 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Chronic Renal Disease in Renal Transplan

✍ G. Fernández-Fresnedo; C. Gómez-Alamillo; J.C. Ruiz; A.L.M. de Francisco; M. Ari 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Endothelin-1 levels and cardiovascular r

✍ Thierry Radeau; Marcel Lebel; Isabelle Houde; Richard Larivière; Pascale Maurièg 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 161 KB

Assessment of Cardiovascular Risk Factor

✍ R. Kumar; J. Brar; R. Yacoub; T. Khan; M. Zachariah; R. Venuto 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 415 KB

Immunosuppressive Agents and Metabolic F

✍ A. Sessa; A. Esposito; A. Giliberti; G. Iavicoli; C. Costa; M. Bergallo; E. Lett 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 152 KB